Leading drug maker GSK posted a revenue of N7.8billion a 12.7% (2013 FY: N6.9billion). Gross profit also increased 8.8% to N2.9billion compared to N2.7billion. Pre-tax was N892million compared to N865million a 3.2% rise.
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |